Stock comparison
DEXCOM INC is 1.0x more valuable than RESMED INC by market capitalization ($32.33 B vs $31.88 B). Compare market value, revenue, profit, margins, filings, and source pages in one place.
Quick answer
DXCM is larger
DEXCOM INC is 1.0x more valuable than RESMED INC by market capitalization ($32.33 B vs $31.88 B).
Market value leader
DXCM
DEXCOM INC is 1.0x more valuable than RESMED INC by market capitalization ($32.33 B vs $31.88 B).
Revenue leader
RMD
DXCM: $4.66B vs RMD: $5.15B.
Profit leader
RMD
DXCM: $836.30M vs RMD: $1.40B.
Margin leader
RMD
DXCM: 17.9% vs RMD: 27.2% net margin.
| Metric | DXCM | RMD |
|---|---|---|
| Market cap | $32.33 B | $31.88 B |
| US-listed rank | #445 | #448 |
| Revenue (latest FY) | $4.66B | $5.15B |
| Net income (latest FY) | $836.30M | $1.40B |
| Net margin | 17.9% | 27.2% |
| P/E (trailing FY) | 38.7x | 22.8x |
| SEC filings | 2,566 | 2,518 |
Jump from this comparison into the underlying pages for market value, annual fundamentals, and company filing history.
Market cap uses refreshed market data. Revenue, net income, margins, and trailing fiscal-year P/E use annual company facts from filings. If a metric is missing, the source data did not have a clean recent annual value for that company.
DEXCOM INC is 1.0x more valuable than RESMED INC by market capitalization ($32.33 B vs $31.88 B).
In their latest fiscal years, DEXCOM INC reported $4.66B in revenue while RESMED INC reported $5.15B.
Full pages: DEXCOM INC and RESMED INC, or browse the full rankings.